Frequently Asked Questions
This FAQ page is designed to answer common questions from patients, prescribers, and biopharma partners seeking support for rare and ultrarare therapies. Our exclusive model, integrated services, and rare disease culture set us apart.
General Questions
What is Anovo (AnovoRx)?
Anovo is an exclusive rare disease specialty pharmacy and independent commercialization partner, built to support patients, caregivers, and therapy developers across the full continuum of rare and ultra-rare disease care. We offer an integrated model that combines specialty pharmacy, patient support hub services, and 3PL distribution — all under one roof.
Where is Anovo located?
We are headquartered in Memphis, Tennessee, have a distribution center in Phoenix, Arizona, and are licensed to operate nationwide. Our integrated facility supports providers and patients across all 50 U.S. states, with centralized coordination to streamline care and delivery.
Looking for support in your area? Anovo serves patients and prescribers from Memphis to Miami, and Seattle to Boston — offering a consistent and compliant care experience coast to coast.
What makes Anovo different from other specialty pharmacies?
Unlike traditional specialty pharmacies, Anovo is purpose-built for exclusive rare disease therapy distribution. Our integrated hub, pharmacy, and 3PL model eliminates the need for multiple vendors and handoffs — reducing delays and increasing patient and partner satisfaction.
For Prescribers
How does Anovo support prescribers of rare disease therapies?
We simplify the prescribing process through a dedicated team, a single point of contact, and services like benefit verification, PA support, REMS management, and adherence tracking. Our rare disease-specialized pharmacy team becomes an extension of your practice.
Does Anovo support Early Access or Compassionate Use Programs?
Yes. We are experienced in managing Early Access Programs (EAPs) and pre-commercial launches for rare and ultrarare therapies. Our clinical and operational infrastructure is designed to support these complex programs while maintaining compliance and continuity.
For Manufacturers
Can Anovo serve as the exclusive partner for my therapy?
Absolutely. Anovo has supported multiple rare disease manufacturers through exclusive pharmacy partnerships. Our fully integrated platform allows for centralized data, real-time reporting, and a direct relationship with patients and providers.
Do you offer commercialization support for pre-launch therapies?
Yes. We work with emerging biotech teams as a commercialization partner, helping define the service model, patient journey, data reporting, and operational requirements before product approval.
How does your data reporting and analytics work?
We provide real-time reporting via customizable dashboards — including adherence metrics, dispense history, patient milestones, payer status, and more. Our system gives partners one source of truth with no data gaps between vendors.
For Patients & Caregivers
How do I fill my prescription with Anovo?
Once your prescriber submits a prescription, our team will contact you to walk through benefits, support options, and delivery scheduling. You’ll have a dedicated point of contact throughout your treatment.
Where does Anovo deliver medications?
We ship prescriptions directly to patients’ homes, hospitals, or provider offices across the United States. All shipments are temperature-controlled, tracked, and supported by our pharmacy team.
Can Anovo help me afford my medication?
Yes. We support patients through copay assistance programs, manufacturer-provided patient assistance programs (PAP), and alternative funding pathways whenever possible. Our team helps you navigate every step.
Does Anovo support patients and providers in my state?
Yes. Anovo is a nationwide rare disease specialty pharmacy licensed in all 50 states.